State Street Corp Rani Therapeutics Holdings, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, State Street Corp holds 62,442 shares of RANI stock, worth $39,338. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,442
Previous 62,442
-0.0%
Holding current value
$39,338
Previous $85,000
8.24%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RANI
# of Institutions
44Shares Held
3.47MCall Options Held
44.3KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA800KShares$503,7970.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$310,9570.6% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$282,5490.05% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$190,7280.01% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$123,6160.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $15.4M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...